Impaired nonhomologous end-joining provokes soft tissue sarcomas harboring chromosomal translocations,
N E Sharpless1, D O Ferguson, R C O'Hagan
1Department of Adult Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.
Abstract:
Although nonhomologous end-joining (NHEJ) deficiency has been shown to accelerate lymphoma formation in mice, its role in suppressing tumors in cells that do not undergo V(D)J recombination is unclear. Utilizing a tumor-prone mouse strain (ink4a/arf(-/-)), we examined the impact of haploinsufficiency of a NHEJ component, DNA ligase IV (Lig4), on murine tumorigenesis. We demonstrate that lig4 heterozygosity promotes the development of soft-tissue sarcomas that possess clonal amplifications, deletions, and translocations. That these genomic alterations are relevant in tumorigenesis is supported by the finding of frequent mdm2 amplification, a known oncogene in human sarcoma. Together, these findings support the view that loss of a single lig4 allele results in NHEJ activity being sufficiently reduced to engender chromosomal aberrations that drive non-lymphoid tumorigenesis.
Insights
Reduced DNA ligase IV (Lig4) activity in mice accelerates non-lymphoid tumor formation. Haploinsufficiency of Lig4 leads to genomic instability and soft-tissue sarcomas, highlighting its role in cancer suppression.
Area of Science:
- Genetics
- Cancer Biology
- Genomic Instability
Background:
- Nonhomologous end-joining (NHEJ) is crucial for DNA repair.
- NHEJ deficiency accelerates lymphoma but its role in other cancers is unclear.
Purpose of the Study:
- To investigate the role of DNA ligase IV (Lig4) haploinsufficiency in non-lymphoid tumorigenesis.
- To determine if reduced NHEJ activity drives cancer in cells without V(D)J recombination.
Main Methods:
- Utilized ink4a/arf(-/-) tumor-prone mice.
- Examined the effect of lig4 heterozygosity on tumor development.
- Analyzed genomic alterations in tumors, including amplifications, deletions, and translocations.
Main Results:
- Lig4 heterozygosity promoted soft-tissue sarcoma development in mice.
- Tumors exhibited clonal genomic aberrations like amplifications, deletions, and translocations.
- Frequent mdm2 amplification, an oncogene in human sarcoma, was observed.
Conclusions:
- Loss of a single lig4 allele sufficiently reduces NHEJ activity.
- Reduced NHEJ activity leads to chromosomal aberrations that drive non-lymphoid tumorigenesis.
- Lig4 plays a significant role in suppressing non-lymphoid cancers.
Related Concept Videos
Nucleotide Excision Repair
Fixing Double-strand Breaks
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Nucleotide Excision Repair
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
Fixing Double-strand Breaks
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...


